Patients with medically unexplained symptoms in general practice
Authors:
M. Seifert 1,2,3; A. Šebela 4,5
Authors‘ workplace:
Univerzita Karlova v Praze, 3. lékařská fakulta Kabinet praktického lékařství Vedoucí: MUDr. Martin Seifert
1; Univerzita Karlova v Praze, 1. lékařská fakulta Ústav všeobecného lékařství Přednosta: doc. MUDr. Bohumil Seifert, Ph. D.
2; Univerzita Karlova v Praze, 1. lékařská fakulta Psychiatrická klinika Přednosta: doc. MUDr. Martin Anders, Ph. D.
3; Národní ústav duševního zdraví, Klecany Ředitel: PhDr. Petr Winkler, Ph. D.
4; Univerzita Karlova v Praze, 3. lékařská fakulta a Národní ústav duševního zdraví, Klecany Klinika psychiatrie a lékařské psychologie Přednosta: prof. MUDr. Jiří Horáček, Ph. D.
5
Published in:
Prakt. Lék. 2022; 102(3): 103-121
Category:
Editorial
Overview
Patients with medically unexplained symptoms make up a significant proportion of patients in general practice and can be very burdensome for doctors and the whole health and social care system. In this review, the authors summarize the most important current knowledge about the incidence, causes, and mechanisms of physical complaints without an organic cause, the characteristics of patients with these complaints, and their prognosis. In addition, the authors focus on the diagnostic and therapeutic options for these patients, particularly interventions applicable in primary care. Finally, they discuss this issue in the Czech context, present their research agenda and call for changes that would lead to improved care of patients with medically unexplained symptoms.
Keywords:
Primary care – general practitioner – bio-psycho-social – medically unexplained symptoms – somatization disorder – basic psychosomatic care
Sources
1. Olde Hartman TC, Woutersen-Koch H, Van der Horst HE. Medically unexplained symptoms: evidence, guidelines, and beyond. Br J Gen Pract 2013; 63(617): 625–626.
2. de Waal MW, Arnold IA, Eekhof JA, van Hemert AM. Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 2004; 184: 470–476.
3. Steinbrecher N, Koerber S, Frieser D, Hiller W. The prevalence of medically unexplained symptoms in primary care. Psychosomatics 2011; 52(3): 263–271.
4. Aamland A, Malterud K, Werner EL. Patients with persistent medically unexplained physical symptoms: a descriptive study from Norwegian general practice. BMC Fam Pract 2014; 15: 107.
5. Rask MT, Ørnbøl E, Rosendal M, Fink P. Long-term outcome of bodily distress syndrome in primary care: a follow-up study on health care costs, work disability, and self-rated health. Psychosom Med 2017; 79(3): 345–357.
6. van der Leeuw G, Gerrits MJ, Terluin B, et al. The association between somatization and disability in primary care patients. J Psychosom Res 2015; 79(2): 117–122.
7. Dirkzwager AJ, Verhaak PF. Patients with persistent medically unexplained symptoms in general practice: characteristics and quality of care. BMC Fam Pract 2007; 8: 33.
8. Page L, Wessely S. Medically unexplained symptoms: exacerbating factors in the doctor-patient encounter. J R Soc Med 2003; 96(5): 223–227.
9. Woivalin T, Krantz G, Mäntyranta T, Ringsberg KC. Medically unexplained symptoms: perceptions of physicians in primary health care. Fam Pract 2004; 21(2): 199–203.
10. Shevlin M, Nolan E, Owczarek M, et al. COVID-19-related anxiety predicts somatic symptoms in the UK population. Br J Health Psychol 2020; 25: 875–882.
11. Winkler P, Formanek T, Mlada K, et al. Increase in prevalence of current mental disorders in the context of COVID-19: analysis of repeated nationwide cross-sectional surveys. Epidemiol Psychiatr Sci 2020; 29: e173.
12. Raboch J, a kol. DSM-5. Praha: Hogrefe Testcentrum 2015.
13. American Psychiatric Association. Division of Research. Highlights of Changes from DSM-IV to DSM-5. FOCUS 2013; 11(4): 525–527.
14. Dwamena FC, Lyles JS, Frankel RM, Smith RC. In their own words: qualitative study of high-utilising primary care patients with medically unexplained symptoms. BMC Fam Pract 2009; 10: 67.
15. Edwards TM, Stern A, Clarke DD, et al. The treatment of patients with medically unexplained symptoms in primary care: a review of the literature. Ment Health Fam Med 2010; 7(4): 209–221.
16. Lipowski ZJ. Somatization: the concept and its clinical application. Am J Psychiatry 1988; 145(11): 1358–1368.
17. Tress W, Krusse J, Ott J. Základní psychosomatická péče. Praha: Portál 2008.
18. Burton C, Lucassen P, Aamland A, Olde Hartman T. Explaining symptoms after negative tests: towards a rational explanation. J R Soc Med 2015; 108(3): 84–88.
19. Hubley S, Uebelacker L, Eaton C. Managing medically unexplained symptoms in primary care: a narrative review and treatment recommendations. Am J Lifestyle Med 2014; 10(2): 109–119.
20. Holmes TH, Rahe RH. The Social Readjustment Rating Scale. J Psychosom Res 1967; 11(2): 213–218.
21. Chvála V, Honzák R, Seifert M, a kol. Psychosomatické poruchy a lékařsky nevysvětlitelné příznaky. Doporučený postup SVL ČLS JEP. Vydání 1. 2015 [online]. Dostupné z: www.svl.cz/files/files/ Doporucene-postupy-od-2013/Psychosomaticke-poruchy-alekarsky- nevysvetlitelne-priznaky.pdf [cit. 2022-06-12].
22. Olde Hartman TC, Blankenstein AH, Molenaar B, et al. NHG Standaard SOLK. [NHG Guideline on medically unexplained symptoms (MUS)] Huisarts Wet 2013; 56(5): 222–230.
23. Wonca working party on mental health. Addressing the needs of patients with Medically Unexplained Symptoms (MUS), 2018 [online]. Dostupné z: www.globalfamilydoctor.com/site/ DefaultSite/filesystem/documents/Groups/Mental%20Health/ MUS%2018.pdf [cit. 2022-06-12].
24. Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977; 196(4286): 129–136.
25. Brown RJ. Psychological mechanisms of medically unexplained symptoms: an integrative conceptual model. Psychol Bull 2004; 130(5): 793–812.
26. Rief W, Broadbent E. Explaining medically unexplained symptoms- models and mechanisms. Clin Psychol Rev 2007; 27(7): 821–841.
27. Henningsen P. Management of somatic symptom disorder. Dialogues Clin Neurosci 2018; 20(1): 23–31.
28. Damasio A. Looking for Spinoza: Joy, Sorrow, and the Feeling Brain. Orlando: Harcourt 2003.
29. Denk F, McMahon SB, Tracey I. Pain vulnerability: a neurobiological perspective. Nat Neurosci 2014; 17(2): 192–200.
30. Maunder RG, Hunter JJ, Atkinson L, et al. An attachment-based model of the relationship between childhood adversity and somatization in children and adults. Psychosom Med 2017; 79(5): 506–513.
31. Trapková L, Chvála V. Rodinná terapie psychosomatických poruch. Praha: Portál 2004.
32. Chvála V. Dvacetiletá zkušenost s léčbou pacientů s psychosomatickou poruchou ve středisku komplexní terapie v Liberci. Psychosom 2009; 2: 93–103.
33. Salmon P, Humphris GM, Ring A, et al. Why do primary care physicians propose medical care to patients with medically unexplained symptoms? A new method of sequence analysis to test theories of patient pressure. Psychosom Med 2006; 68(4): 570–577.
34. Stone L. Managing medically unexplained illness in general practice. Aust Fam Physician 2015; 44(9): 624–662.
35. Kurlansik SL, Maffei MS. Somatic Symptom Disorder. Am Fam Physician 2016; 93(1): 49–54.
36. Tomenson B, Essau C, Jacobi F, et al. Total somatic symptom score as a predictor of health outcome in somatic symptom disorders. Br J Psychiatry 2013; 203(5): 373–380.
37. Derogatis LR, Savitz KL. The SCL-90-R and Brief Symptom Inventory (BSI) in primary care. In Maruish ME (Ed.). Handbook of psychological assessment in primary care settings. Mahwah, NJ: Lawrence Erlbaum Associates Publishers 2000; 297–334.
38. Kabát J, Kaščáková N, Furstová J, a kol. Psychometrické charakteristiky české verze stručného inventáře příznaků (BSI-53). Ces Psychol 2008; 62(Supl 1): 19–39.
39. Terluin B, van Marwijk HW, Adèr HJ, et al. The Four-Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. BMC psychiatry 2006; 6: 34.
40. Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 2003; 65(4): 528–533.
41. Donnachie E, Schneider A, Enck P. Comorbidities of patients with functional somatic syndromes before, during and after first diagnosis: a population-based study using Bavarian routine data. Sci Rep 2020; 10: 9810.
42. Kurtz S, Silverman J, Benson J, Draper J. Marrying content and process in clinical method teaching: enhancing the Calgary- Cambridge guides. Acad Med 2003; 78(8): 802–809.
43. Danish College of General Practitioners’. Danish clinical Guidelines DSAM: Functional disorders. 2015 [online]. Dostupné z: http//vejledninger.dsam.dk/media/files/10/ clinical-guideline-functional-disorders-dsam-2013.pdf [cit. 2022–06–12].
44. Kurlansik SL, Maffei MS. Somatic Symptom Disorder. Am Fam Physician 2016; 93(1): 49–54.
45. McCarron RM. Somatization in the primary care setting. Psychiatric Times 2006; 23(6): 32.
46. Edwards TM, Stern A, Clarke DD, et al. The treatment of patients with medically unexplained symptoms in primary care: a review of the literature. Ment Health Fam Med 2010; 7(4): 209–221.
47. Peters S, Rogers A, Salmon P, et al. What do patients choose to tell their doctors? Qualitative analysis of potential barriers to reattributing medically unexplained symptoms. J Gen Intern Med 2008; 24(4): 443–449.
48. Řiháček T, Pavlenko P, Franke H. Účinnost psychoterapeutických postupů u pacientů s medicínsky nevysvětlenými tělesnými symptomy: Shrnutí metaanalýz a přehledových studií. Cesk Psychol 2017; 6: 350–362.
49. Wortman MSH, Olde Hartman TC, van der Wouden JC, et al. Perceived working mechanisms of psychosomatic therapy in patients with persistent somatic symptoms in primary care: a qualitative study. BMJ Open 2022; 12(1): e057145.
50. Cooper A, Abbass A, Town J. Implementing a psychotherapy service for medically unexplained symptoms in a primary care setting. J Clin Med 2017; 6(12): 109.
51. Rosendal M, Blankenstein AH, Morriss R, et al. Enhanced care by generalists for functional somatic symptoms and disorders in primary care. Cochrane Database Syst Rev 2013; (10): CD008142.
52. Gerger H, Hlavica M, Gaab J, et al. Does it matter who provides psychological interventions for medically unexplained symptoms? A meta-analysis. Psychother Psychosom 2015; 84(4): 217–226.
53. Leaviss J, Davis S, Ren S, et al. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation. Health Technol Assess 2020; 24(46): 1–490.
54. Sansone RA, Tahir NA, Buckner VR, Wiederman MW. The relationship between borderline personality symptomatology and somatic preoccupation among internal medicine outpatients. Prim Care Companion J Clin Psychiatry 2008; 10(4): 286–290.
55. Zipfel S, Herzog W, Kruse J, Henningsen P. Psychosomatic medicine in Germany: more timely than ever. Psychother Psychosom 2016; 85(5): 262–269.
56. Kruse J, Larisch A, Hofmann M, Herzog W. Ambulante psychosomatische und psychotherapeutische Versorgung in Deutschland: Versorgungsprofile abgebildet durch Daten der Kassenärztlichen Bundesvereinigung (KBV). Z Psychosom Med Psychother 2013; 59(3): 254–272.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2022 Issue 3
Most read in this issue
- Giardiasis, one of the most important parasitic diseases in the world
- Lung cancer and its screening from the perspective of a general practitioner
- Patients with medically unexplained symptoms in general practice
- Problematics of administration of risky medicinal products by the general nurse